Safety and Efficacy of Combined Venous Sinus Balloon Protection Technique in transarterial Embolization of Low-and intermediate-grade Transverse-Sigmoid Sinus Dural Arteriovenous Fistulas: A Cohort of 161 patients

医学 放射科 栓塞 乙状窦 窦(植物学) 动静脉瘘 气球 外科 植物 血栓形成 生物
作者
Huiwei Liu,Zihao Song,Xin Su,H. Zhang,Ming Ye,Yongjie Ma,Peng Zhang
出处
期刊:American Journal of Neuroradiology [American Society of Neuroradiology]
卷期号:: ajnr.A8709-ajnr.A8709
标识
DOI:10.3174/ajnr.a8709
摘要

The venous sinus balloon protection technique is regarded as a safe and effective method for treating transverse-sigmoid sinus (TSS) dural arteriovenous fistulas (DAVFs). However, large cohort studies on this technology are still lacking. This study aims to present a large single-center experience on the safety and efficacy of venous sinus balloon protection in the treatment of TSS DAVFs. We conducted a retrospective review of our database, identifying all patients with low-and intermediate-grade TSS-DAVFs who underwent transarterial embolization (TAE) between 2002 and 2020. The patients were categorized into two groups: the Venous Sinus Balloon Protection (VSBP) group and the Non-Venous Sinus Balloon Protection (NVSBP) group, based on the use of the venous sinus balloon protection technique. The safety and efficacy of the venous sinus balloon protection technique were subsequently analyzed. The study included 161 patients with low-and intermediate-grade TSS-DAVFs who received TAE, comprising 72 individuals in the VSBP group and 89 in the NVSBP group. The objective of the study was to evaluate the safety and efficacy of sinus balloon protection by comparing clinical and angiographic outcomes, as well as complication rates, between the two groups. Favorable clinical outcomes were similar between the two groups (VSBP 93.1% vs. NVSBP 96.6%, P=0.501), with no statistically significant difference in the incidence of the rate of complications (VSBP 1.4% vs. NVSBP 2.2%, P=1.000). However, the rate of complete occlusion was significantly higher in the VSBP group compared to the NVSBP group (87.5% vs. 69.7%, P=0.007). The sinus balloon protection technique demonstrates excellent safety and effectiveness, significantly improving the complete occlusion rate of low-and intermediate-grade TSS-DAVFs in the near term, without increasing the incidence of complications. In the future, larger prospective cohorts are needed to further elucidate and confirm the safety and effectiveness of the sinus balloon protection technique for all dural arteriovenous fistulas. Dural arteriovenous fistula; Transverse-sigmoid sinus; Transarterial embolization; Venous sinus balloon protection.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
子非鱼完成签到 ,获得积分10
刚刚
刚刚
犇骉发布了新的文献求助10
2秒前
wuwu完成签到,获得积分20
2秒前
善学以致用应助舒心采纳,获得10
2秒前
2秒前
2秒前
SPULY发布了新的文献求助10
2秒前
3秒前
pxy发布了新的文献求助10
4秒前
梦香馨完成签到 ,获得积分10
4秒前
5秒前
内向灵凡完成签到,获得积分10
5秒前
倩倩应助科研通管家采纳,获得10
5秒前
5秒前
英俊的铭应助科研通管家采纳,获得10
5秒前
小马甲应助科研通管家采纳,获得10
5秒前
慕青应助科研通管家采纳,获得10
5秒前
桐桐应助科研通管家采纳,获得10
5秒前
天天快乐应助科研通管家采纳,获得10
5秒前
等待听安完成签到 ,获得积分10
5秒前
王汉堡应助科研通管家采纳,获得10
5秒前
彭于晏应助科研通管家采纳,获得10
5秒前
5秒前
今后应助科研通管家采纳,获得10
5秒前
星辰大海应助科研通管家采纳,获得10
5秒前
XLJ应助科研通管家采纳,获得10
5秒前
上官若男应助科研通管家采纳,获得10
5秒前
彭于晏应助科研通管家采纳,获得10
6秒前
在水一方应助科研通管家采纳,获得30
6秒前
LaTeXer应助科研通管家采纳,获得50
6秒前
Owen应助科研通管家采纳,获得10
6秒前
所所应助科研通管家采纳,获得10
6秒前
Lucas应助科研通管家采纳,获得10
6秒前
安静的芷天完成签到,获得积分10
6秒前
研友_Raven发布了新的文献求助10
6秒前
7秒前
牛牛牛发布了新的文献求助10
7秒前
英俊的铭应助小落采纳,获得10
8秒前
Ava应助现代柠檬采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Materials Selection in Mechanical Design 1000
Voyage au bout de la révolution: de Pékin à Sochaux 700
First Farmers: The Origins of Agricultural Societies, 2nd Edition 500
Simulation of High-NA EUV Lithography 400
Metals, Minerals, and Society 400
International socialism & Australian labour : the Left in Australia, 1919-1939 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4309232
求助须知:如何正确求助?哪些是违规求助? 3830969
关于积分的说明 11986965
捐赠科研通 3471161
什么是DOI,文献DOI怎么找? 1903292
邀请新用户注册赠送积分活动 950557
科研通“疑难数据库(出版商)”最低求助积分说明 852441